MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

Search

Stevanato Group SpA

Cerrado

SectorSanidad

17.2 -9.52

Resumen

Variación precio

24h

Actual

Mínimo

16.66

Máximo

17.35

Métricas clave

By Trading Economics

Ingresos

10M

49M

Ventas

23M

303M

P/B

Media del Sector

33.475

89.037

BPA

0.162

Rentabilidad por dividendo

0.26

Margen de beneficios

16.205

Empleados

5,521

EBITDA

10M

73M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+56.34% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.26%

2.18%

Próximas Ganancias

5 mar 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-1.3B

5.4B

Apertura anterior

26.72

Cierre anterior

17.2

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

142 / 352 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

Stevanato Group SpA Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

23 ene 2026, 18:41 UTC

Ganancias

SLB Readies Rapid Expansion in Venezuela -- 2nd Update

24 ene 2026, 09:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

24 ene 2026, 09:20 UTC

Charlas de Mercado
Ganancias

Tech, Media & Telecom Roundup: Market Talk

24 ene 2026, 09:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

24 ene 2026, 09:20 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

24 ene 2026, 06:18 UTC

Adquisiciones, fusiones, absorciones

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

23 ene 2026, 22:30 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

23 ene 2026, 22:30 UTC

Charlas de Mercado

Trump Seen Using Canada's EV Deal With China to Extract Concessions -- Market Talk

23 ene 2026, 22:03 UTC

Ganancias

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

23 ene 2026, 21:52 UTC

Ganancias
Adquisiciones, fusiones, absorciones

GE Aerospace's Earnings Worried the Market. What CEO Larry Culp Says. -- Barrons.com

23 ene 2026, 21:50 UTC

Charlas de Mercado
Ganancias

Tech, Media & Telecom Roundup: Market Talk

23 ene 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

23 ene 2026, 21:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

23 ene 2026, 21:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

23 ene 2026, 21:39 UTC

Ganancias

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 5th Update

23 ene 2026, 21:15 UTC

Adquisiciones, fusiones, absorciones

Eaton Completes Acquisition Of Ultra PCS Limited, Expanding Capabilities And Solutions For Next-generation Aerospace And Defense Markets >ETN

23 ene 2026, 21:12 UTC

Ganancias

CSX Stock Rises After Earnings Miss Estimates. It's the Outlook. -- Barrons.com

23 ene 2026, 20:31 UTC

Ganancias

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

23 ene 2026, 20:12 UTC

Charlas de Mercado

Oil Futures Rebound on Iran, Russia-Ukraine Risk -- Market Talk

23 ene 2026, 20:07 UTC

Charlas de Mercado

U.S. Natural Gas Posts Record Weekly Gain on Winter Storm -- Market Talk

23 ene 2026, 19:36 UTC

Charlas de Mercado

Dollar Weakens Against Yen Amid Intervention Chatter -- Market Talk

23 ene 2026, 19:30 UTC

Charlas de Mercado
Ganancias

Intel's Stock Has Limited Catalysts Ahead, Analysts Say -- Market Talk

23 ene 2026, 19:18 UTC

Charlas de Mercado

Gold and Silver Step Up to More Records -- Market Talk

23 ene 2026, 19:15 UTC

Ganancias

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 4th Update

23 ene 2026, 18:53 UTC

Charlas de Mercado

U.S. Oil Rig Count Rises By 1 to 411 -- Market Talk

23 ene 2026, 18:21 UTC

Ganancias

Week's Best: Schwab's Assets and Profits Keep Climbing -- Barrons.com

23 ene 2026, 18:19 UTC

Charlas de Mercado

Intel Seen as Increasingly Confident on Demand -- Market Talk

23 ene 2026, 17:59 UTC

Ganancias

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 3rd Update

23 ene 2026, 17:57 UTC

Charlas de Mercado

Intel Could Sign Deals With Big Tech Players for 14A -- Market Talk

23 ene 2026, 17:57 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Stevanato Group SpA previsión

Precio Objetivo

By TipRanks

56.34% repunte

Estimación a 12 Meses

Media 27 USD  56.34%

Máximo 30 USD

Mínimo 24 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Stevanato Group SpA Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

3 ratings

2

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

21.56 / 22.61Soporte y Resistencia

Corto Plazo

Weak Bullish Evidence

Medio plazo

Weak Bearish Evidence

Largo Plazo

Bullish Evidence

Sentimiento

By Acuity

142 / 352 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
help-icon Live chat